Case 30 - pheochromocytoma Flashcards

1
Q

What is pheochromocytoma?

A
  • neuroendocrine tumor arising from adrenal gland
    • specifically from chromaffin cells that syntehsize catecholamines
  • result: proliferation of NE, Epi, dopamine
  • can be part of a syndrome (MEN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the signs and symptoms of pheochromocytoma?

A

dependent on which catecholamine excess is predominant

Norepi

  • HTN
  • h/a
  • sweating
  • pallor
  • bradycardia

Epi

  • palipations
  • tachy
  • panic/anxiety
  • tremors
  • hyperglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Could there be anything else on your differential besides pheochromocytoma?

A
  • thyrotoxicosis
  • nuerolpetic malignant syndrome
  • malignant hyperthermia
  • pre-eclmpsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can you diagnose pheochromocytoma?

A
  • s/sx + lab testing
  • elevated levels of metaneprhine and normetanephrine in plasma and/or 24 h urine collection

imaging studies

  • helps locate tumor and surgical planning

Echo

  • consider obtaining to detect cardiomyopathy (2/2 pheo mediated HTN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is pheochromo managed preoperatively?

A

Initial goal –> block the toxic effects of catecholamines to prevent and reverse end-organ damage.

1) alpha adrenergic antagonists

  • first line therapy
  • blocks alpha 1 induced vasoconstriction
  • Phenoxybenzamine or phentolamine - nonselective
  • prazosin (-zosin) - selective alpha 1
  • SE: orthostatic hypotension

2) CCB
* used as second agent to refarctory HTN from alpha blockers
3) BB

  • only use after alpha 1 blockade is achieved
    • giving BB prior to alpha blockade leads to unopposed alpha 1 agonism –> further vasoconstriction
  • typically given for epi secreting tumors or patients who developed tachy from vasodilator therapy.
  • beta 1 selective or mixed beta and alpha
    • mixed beta and alpha (labetolol) not used 1st line therapy due to weak alpha effects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the intraop surgical and anesthetic considerations for pheochromo?

A
  • surgical resection is definitive tx
  • occlusion of draining vein (adrenal vein) is desirable early in procedure to decrease catecholamine release into circulation during manipulation of tumor

1) HD instability / blood loss

  • large bore peripheral IV access
  • arterial line –> serial abg, beat to beat monitor, HD instability
  • CVC –> central circulation, vasoactive infusion, poor peripheral iv access, volume resuscitation
  • PAC / TEE - cardiomyopathy, CHF, heart pressures, thermodilution CO

2) vasoactive infusions

  • fast on and off, easy to titrate
  • hypotension –> phenylephrine, norepi
  • HTN –> nitroprusside or nitroglcerin
  • SVT/ventricular dysrhythmia –> BB or lidocaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what stimuli has been implicated in provoking catecholamine surges during procedure?

A

Factors: Anesthetic Factors, Surgical Factors, Medicatoins

Anesthesia:

  • intubation
  • light anesthesia
  • pain with surgery

Surgical:

  • skin incision
  • surgical manipulation of tumor

Meds:

  • SUX -> fasciculation of abdomen can compress tumor and cause catecholamine release
  • meds with histamine release
    • morphine, demerol, atracurium
  • meds with undesider autonomic effects
    • pancoronium, ephedrine, ketamine

most IV anes agents, opioids, neuromusuclar blockers, and inhaled agents are safe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are postoperative concerns in pheo patients?

A
  • post op hypotension
    • adrenal insuffiency -> lack of catecholamine output
    • persistent adrenergic blockade from preop or intraop meds
    • bleeding
  • Post op HTN
    • residual tumor
    • stored catecholamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly